๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Allogeneic Hematopoietic Stem Cell Transplantation
Clinical trial register · China

Allogeneic Hematopoietic Stem Cell Transplantation Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Wuhan 4 Shanghai 4 Beijing 3 Zhengzhou 2 Hangzhou 2
Narrow the registerReset
Recruitment status
Phase
Site location
Wuhan4 Shanghai4 Beijing3 Zhengzhou2 Hangzhou2
All 13 locations
Target enrolment
to

Allogeneic Hematopoietic Stem Cell Transplantation trials in China

14 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Efficacy and Safety of Romiplostim N01 for Injection in Promoting Platelet Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation
NCT07829952Thrombocytopenia, Allogeneic Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Henan University of Science and Technology
Phase 2
87
Luoyang
2026-11-01
Not yet open
Younger vs. Older Donors in Allo-HSCT: TTE
NCT07666568A Target Trial Emulation Study, Donor Age, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
The First Affiliated Hospital of Soochow University
Observational
5,000
Suzhou
2026-07-15
Not yet open
A Randomized Controlled Trial of Prophylactic Rituximab to Reduce Clinically Significant EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation
NCT07703657Allogeneic Hematopoietic Stem Cell Transplantation, Epstein-Barr Virus Reactivation, Clinically Significant EBV DNAemia
Yang Donglin
Not applicable
168
Tianjin
2026-07-09
Recruiting
Baricitinib for Post-HSCT Persistent Thrombocytopenia
NCT07535645Persistent Thrombocytopenia, Allogeneic Hematopoietic Stem Cell Transplantation
Peking University People's Hospital
Phase 1/2
28
Beijing
2026-03-09
Recruiting
Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial
NCT07396480Venentoclax, Myeloid Malignancies, Conditioning, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
First Affiliated Hospital of Zhejiang University
Phase 3
186
Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Jinan, Hangzhou
2026-03-01
Recruiting
Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT
NCT06946654Elderly, Geriatric Assessment, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Peking University People's Hospital
Observational
176
Beijing
2026-01-01
Recruiting
Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
NCT07572669Steroid-Refractory Acute Graft-Versus-Host Disease, Acute Graft-Versus-Host Disease, Graft-Versus-Host Disease, Allogeneic Hematopoietic Stem Cell Transplantation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
42
Wuhan
2025-09-01
Active, closed
Maintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After Transplantation
NCT07094464TP53-mutated MDS and AML, Allogeneic Hematopoietic Stem Cell Transplantation
Daihong Liu
Phase 1
20
Beijing
2025-06-01
By invitation
Acupoint Application With Herbal Fumigation and Wash for Preventing Diarrhea-induced Perianal Infection in Allo-HSCT Patients
NCT06912347Allogeneic Hematopoietic Stem Cell Transplantation
Ruijin Hospital
Not applicable
180
Shanghai
2025-03-18
Not yet open
BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients
NCT06673459T-Cell Lymphocytic Leukemia, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Total Body Irradiation, Chemotherapy
The First Affiliated Hospital of Soochow University
Phase 3
430
Suzhou
2024-12-01
Not yet open
Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation
NCT06704542ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Diabetes Mellitus, Impaired Fasting Glucose
Ruijin Hospital
Observational
1,000
Zhengzhou, Wuhan, Shanghai, Hangzhou, Tianjin
2024-11
Recruiting
Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention
NCT06686108T-cell Acute Lymphoblastic Leukemia, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Relapse
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
59
Shanghai
2024-10-30
By invitation
Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome
NCT05674539Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3
200
Wuhan
2023-02-15
Recruiting
Allogeneic Hematopoietic Stem Cell Transplantation Cohort Study
NCT06708130Allogeneic Hematopoietic Stem Cell Transplantation
Ruijin Hospital
Observational
3,000
Shanghai
2021-05-01
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/allogeneic-hematopoietic-stem-cell-transplantation

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies listing the condition Allogeneic Hematopoietic Stem Cell Transplantation.

How many Allogeneic Hematopoietic Stem Cell Transplantation trials are recruiting in China?

6 of the 14 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 5 have not yet opened recruitment, 1 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Allogeneic Hematopoietic Stem Cell Transplantation), 14 studies
PhaseStudiesRecruitingShare
Observational4228.6%
Phase 23221.4%
Phase 33121.4%
Not applicable2014.3%
Phase 1107.1%
Phase 1/2117.1%

Most active sponsors

Lead sponsors with the most studies (Allogeneic Hematopoietic Stem Cell Transplantation)
Lead sponsorStudiesRecruiting
Ruijin Hospital31
Peking University People's Hospital22
The First Affiliated Hospital of Soochow University20
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology21
Daihong Liu10
First Affiliated Hospital of Zhejiang University11
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine11
The First Affiliated Hospital of Henan University of Science and Technology10
Yang Donglin10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.